These observations place SGLT2 inhibitors as functional antagonists to renal sympathetic nerve hyperactivity in HF, which is the main contributor to norepinephrine spillover [55] and is closely linked to outcome in HF patients [56]. This evidence concerns the gene SLC5A2 and hydrops fetalis.